Calcitriol and Cerebral calcification - a phase IV clinical study of FDA data

Summary:

Cerebral calcification is reported as a side effect among people who take Calcitriol (calcitriol), especially for people who are female, 60+ old, also take Rocaltrol, and have Hypophosphatasia.

The phase IV clinical study analyzes which people have Cerebral calcification when taking Calcitriol. It is created by eHealthMe based on reports of 23,957 people who have side effects when taking Calcitriol from the FDA, and is updated regularly.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.

What is Cerebral calcification?

Cerebral calcification (abnormal deposits of calcium in certain areas of the brain) is found to be associated with 56 drugs and 208 conditions by eHealthMe. Check the latest studies of Cerebral calcification.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

23,957 people reported to have side effects when taking Calcitriol.
Among them, 11 people (0.05%) have Cerebral calcification.

Could Calcitriol cause Cerebral calcification?

Among these 11 people:

What is the gender of people who have Cerebral calcification when taking Calcitriol? *

female: 80 %
male: 20 %

What is the age of people who have Cerebral calcification when taking Calcitriol? *

What are other drugs people take besides Calcitriol? *

What are other side effects people have besides Cerebral calcification? *

Hypokalemia (low potassium): 5 people, 45.45%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 36.36%
Acute Myocardial Infarction (acute heart attack): 4 people, 36.36%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 36.36%
Weakness: 3 people, 27.27%
Pneumonia: 3 people, 27.27%
Hypoglycemia (low blood sugar): 3 people, 27.27%
Gallstones (stone formation by bile component): 3 people, 27.27%
Hyperkalemia (damage to or disease of the kidney): 3 people, 27.27%
Mobility Decreased (ability to move is reduced): 2 people, 18.18%

What are the existing conditions these people have? *

Hypophosphatasia (metabolic bone disease): 2 people, 18.18%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Renal Impairment (severely reduced kidney function): 1 person, 9.09%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 9.09%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Candidiasis (candidiasis or thrush is a fungal infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Calcitriol and have Cerebral calcification?

- Check whether Cerebral calcification is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Calcitriol:

Calcitriol (24,162 reports)

Browse all side effects of Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cerebral calcification:

Cerebral calcification (56 drugs)

Browse all the conditions that are associated with Cerebral calcification:

Cerebral calcification (208 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Calcitriol) and Calcitriol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.